⚠️ RESEARCH USE ONLY - NOT FOR HUMAN CONSUMPTION - NOT APPROVED BY MHRA - 18+ ONLY

Verified Peptides

Semaglutide Research & Scientific Studies

Explore the latest peer-reviewed research and scientific studies

About Semaglutide

Semaglutide is a synthetic GLP-1 receptor agonist used in metabolic and endocrine research. Supplied as a lyophilized powder for laboratory investigations of incretin receptor pharmacology, glucose-regulatory signaling, and downstream pathway activity in controlled experimental systems. Each batch is verified for identity and purity using HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: >95-99(HPLC verified) Storage: Store desiccated at ?20�C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.

Purity>95-99
Categorypeptide

Latest Research

Featured Study

Semaglutide in metabolic dysfunction-associated alcohol-related liver disease: a potential dual-target therapy for metabolic dysfunction and alcohol use.

Nery F et al.Eur J Gastroenterol Hepatol2026

Recent research on Semaglutide: Semaglutide in metabolic dysfunction-associated alcohol-related liver disease: a potential dual-target therapy for metabolic dysfunction and alcohol use.

Read Full Study on PubMed
Featured Study

Short-term comparative effects of semaglutide, either alone or in conjunction with canagliflozin, on early diabetic kidney disease.

Long W et al.Pak J Pharm Sci2026

Recent research on Semaglutide: Short-term comparative effects of semaglutide, either alone or in conjunction with canagliflozin, on early diabetic kidney disease.

Read Full Study on PubMed

Additional Studies

Semaglutide-associated Twiddler syndrome.

Seiler T et al.JCEM Case Rep2026

Recent research on Semaglutide: Semaglutide-associated Twiddler syndrome.

Read on PubMed

[Advances in Anti-Dementia Therapies in Older Adults].

Schnieder M et al.Dtsch Med Wochenschr2026

Recent research on Semaglutide: [Advances in Anti-Dementia Therapies in Older Adults].

Read on PubMed

GLP-1 receptor agonists for weight management and potential thromboembolic risk reduction in high risk population with cancer, diabetes, cardiovascular disease: A systematic review.

Parekh RS et al.Dis Mon2026

Recent research on Semaglutide: GLP-1 receptor agonists for weight management and potential thromboembolic risk reduction in high risk population with cancer, diabetes, cardiovascular disease: A systematic review.

Read on PubMed

Transcriptomics of S3 segment in mice: response to type 1 diabetes, SGLT1/2 inhibition, or GLP1 receptor agonism.

Kim YC et al.Am J Physiol Renal Physiol2026

Recent research on Semaglutide: Transcriptomics of S3 segment in mice: response to type 1 diabetes, SGLT1/2 inhibition, or GLP1 receptor agonism.

Read on PubMed

Glucagon-like Peptide-1 Receptor Agonists and Risk of Nonarteritic Anterior Ischemic Optic Neuropathy: Systematic Review and Meta-Analysis.

Dhivagaran T et al.Neurology2026

Recent research on Semaglutide: Glucagon-like Peptide-1 Receptor Agonists and Risk of Nonarteritic Anterior Ischemic Optic Neuropathy: Systematic Review and Meta-Analysis.

Read on PubMed

Orforglipron (Foundayo) - a second oral GLP-1 receptor agonist for weight loss.

Authors not listedMed Lett Drugs Ther2026

Recent research on Semaglutide: Orforglipron (Foundayo) - a second oral GLP-1 receptor agonist for weight loss.

Read on PubMed

Related Research

Purchase Semaglutide from Verified Peptides

High-purity research peptides with full analytical verification

  • 99% Purity (HPLC Verified)
  • Full Certificate of Analysis
  • Same Day Dispatch
  • Free UK Shipping Over £75
Buy Semaglutide - 99% Purity, Same Day Dispatch

Research Disclaimer

The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.